Patent · US Active

Methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease

US10655184B2 · kind B2 · utility

0Cited by

131References

6Claims

0Family size

Assignee

Interpace Diagnostics Corporation · US

Inventors

Alex Adai · Austin, US
Anna Szafranska-Schwarzbach · Austin, US
Bernard Andruss · Austin, US
Stephan Hahn · Witten, DE

Key dates

Filing date	Apr 19, 2017
Grant date	May 19, 2020
Priority date	—
Expiry date	Apr 19, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/178
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided are methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.